For pharmacists, from Drug Topics: News briefs of interest to pharmacists - Drug Topics

ADVERTISEMENT

ADVERTISEMENT

Latebreakers
For pharmacists, from Drug Topics: News briefs on subjects of interest to pharmacists

Kansas City pharmacists mobilize to fight meth use

October 13, 2008

Criminals buy cold remedies for the pseudoephedrine, which they use to make methamphetamine. Kansas pharmacists are fighting back with MethShield, an electronic program that tracks sales and catches illegal purchasers in the act. It even calls the cops.

West Virginia free clinics face regulation by state pharmacy board

October 13, 2008

Free clinics in West Virginia dispense more than 500,000 prescriptions a year. Earlier this year they came under regulation by the state pharmacy board. Defenders argue that the board is trying to fix something that isn't broken. The board says that patient safety requires oversight.

Government-mandated inhaler switch goes into effect January 1, 2009

September 15, 2008

Pharmacists need to get ready now to help patients make the government-mandated switch from toxic CFC-driven MDIs to environmentally friendly HFA inhalers.

Synthetic heparin touted at ACS meeting

September 15, 2008

A new fully synthetic heparin may be safer and more pure than the current heparin product.

State Medicaid cuts force pharmacists to take drastic measures

September 15, 2008

Cuts in state Medicaid payments for product reimbursements and dispensing fees are forcing pharmacists to cut services and turn away Medicaid patients.

Mercer survey finds pharmacists' salaries on the rise

August 11, 2008

Survey showed that salaries of retail staff pharmacists have risen 5.8% in 2008.

New Medicare law brings relief to pharmacy

August 11, 2008

MIPPA law delays implementation of Medicaid's average manufacturers price for generic drugs until Oct. 1, 2009.

FDA is warning that patients should receive genetic testing before obtaining Ziagen

August 11, 2008

FDA warns about AIDS drug, abacavir, due to increased risk of potentially fatal side effects for some patients.

Merger talks underway between Teva and Barr, Roche and Genentech

August 11, 2008

Teva plans to acquire Barr for $7.6 billion; Roche plans to take over Genentech at $89 a share

Drug Topics Issue
Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION

ADVERTISEMENT

Survey
How many patients per week does your MTM program serve?
None
1-5
6-12
13+
View Results
None
39%
1-5
30%
6-12
13%
13+
17%
View Results

Modern Medicine logoDrug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.

Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.

ADVERTISEMENT

Click here